38.6 F
Fort Worth
Tuesday, October 27, 2020
Health Care 2nd COVID-19 vaccine trial paused over unexplained illness

2nd COVID-19 vaccine trial paused over unexplained illness

Other News

El Paso officials ask residents to stay home for two weeks as COVID-19 hospitalizations surge

By Cassandra Pollock and Julián Aguilar, The Texas Tribune Oct. 25, 2020 "El Paso...

Tarrant County reports 2 COVID deaths on Sunday

Tarrant County Public Health on Sunday reported two COVID-19 deaths. The deceased include a woman from Forest Hill in her 80s and...

Tarrant County reports 4 COVID deaths on Saturday

Tarrant County Public Health on Saturday, Oct. 24 reported four COVID-19 deaths. The deceased include two men in their 70s from Arlington...

Tarrant County reports 2 COVID deaths

Tarrant County Public Health on Thursday, Oct. 22 reported two COVID-19 deaths. The deceased include a man from Arlington in his 80s...


NEW BRUNSWICK, N.J. (AP) — A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.

The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.

The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.
The company declined to reveal any more details about the illness, citing the participant’s privacy.

Temporary stoppages of large medical studies are relatively common. Few are made public in typical drug trials, but the work to make a coronavirus vaccine has raised the stakes on these kinds of complications.
Companies are required to investigate any serious or unexpected reaction that occurs during drug testing. Given that such tests are done on tens of thousands of people, some medical problems are a coincidence. In fact, one of the first steps the company said it will take is to determine if the person received the vaccine or a placebo.

The halt was first reported by the health news site STAT.
Final-stage testing of a vaccine made by AstraZeneca and Oxford University remains on hold in the U.S. as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, the company has said. That company’s testing has restarted elsewhere.

Johnson & Johnson was aiming to enroll 60,000 volunteers to prove if its single-dose approach is safe and protects against the coronavirus. Other vaccine candidates in the U.S. require two shots.

Latest News

Barrett swearing-in differs markedly from ‘superspreader’

By AAMER MADHANI and MARY CLARE JALONICK Associated Press WASHINGTON (AP) — This time they mostly wore masks.

Care N’ Care Health Plan adds Methodist Medical Group

Care N’ Care (HMO/PPO) Health Plan added Methodist Medical Group into its provider network, effective Nov. 1. The group currently employs 227...

El Paso officials ask residents to stay home for two weeks as COVID-19 hospitalizations surge

By Cassandra Pollock and Julián Aguilar, The Texas Tribune Oct. 25, 2020 "El Paso...

Tarrant County reports 2 COVID deaths on Sunday

Tarrant County Public Health on Sunday reported two COVID-19 deaths. The deceased include a woman from Forest Hill in her 80s and...

An epidemiologist explains the new CDC guidance on 15 minutes of exposure and what it means for you

Ryan Malosh, University of Michigan The Centers for Disease...